# PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia

> **NCT05462340** · PHASE1 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 117 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** [18F]ASEM
- **DRUG:** [18F]AZAN

## Key facts

- **NCT ID:** NCT05462340
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-18
- **Primary completion:** 2025-01-07
- **Final completion:** 2025-01-07
- **Target enrollment:** 117 (ACTUAL)
- **Why stopped:** Study recruitment milestones were not met.
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05462340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05462340, "PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05462340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*